Synthesis of heteroaryl-fused pyrazoles as P38 kinase inhibitors

Heterocycles

Volumn 78, Issue 11, 2009, Pages 2811-2826

  Abbot, Sarah C ^a   Billedeau, Roland J ^a   Dewdney, Nolan J ^a   Gabriel, Tobias ^a   Goldstein, David M ^a   McCaleb, Kristen L ^a   Soth, Michael ^a   Trejo Martin, Teresa Alejandra ^a   Zecic, Hasim ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

Cyclization; Difluorophenol; Pyrazolopyrazine; Pyrazolopyridine; Pyrazolopyrimidine

Indexed keywords

EID: 75849145697     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/COM-09-11808     Document Type: Article

References (8)

1. Jones R.E. Bull. Rheum. Dis. 48 (1999) 1
2. Tumor Necrosis Factor Antagonists as Potential Treatments in Rheumatoid Arthritis. A CME Satellite Symposium at the American College of Rheumatology Annual Meeting, held 12 November 1998 in San Diego, California.J. Rheum. Suppl. (1999) 57
3. Hommes D. Gastroenterology 122 (2002) 7
4. Adams J.L. Prog. Med. Chem. 38 (2001) 1
5. Lee J.C. Immunopharmacology 47 (2000) 185
6. Gay S. Curr. Opinion Rheumatology 20 (2008) 257
7. Voulgari P. Expert Opin. Emerging Drugs 13 1 (2008) 175
8. Xie L., Han B., Xu Y., and Maynard G. Preparation of 3-(imidazol-1-ylmethyl) pyridazines as GABAA receptor ligands (2004) WO2004031174